Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

Teva Jumps as New CEO Jeremy Levin Set to Give Guidance Update

Don't Miss Out —
Follow us on:

May 24 (Bloomberg) -- Teva Pharmaceutical Industries Ltd. rose the most in almost two months before new Chief Executive Officer Jeremy Levin gives an update on financial guidance.

The stock of the world’s largest generic drugmaker jumped the most since April 1, adding 2.4 percent to 153 shekels at 2:36 p.m. in Tel Aviv.

To contact the reporter on this story: David Wainer in Tel Aviv at dwainer3@bloomberg.net

To contact the editor responsible for this story: Claudia Maedler at cmaedler@bloomberg.net

Please upgrade your Browser

Your browser is out-of-date. Please download one of these excellent browsers:

Chrome, Firefox, Safari, Opera or Internet Explorer.